Thermo Fisher Scientific Inc. (NYSE:TMO) was analyzed by Jim Cramer, who favored Danaher over TMO due to better performance. TMO offers life sciences solutions, but Cramer advised caution due to Chinese market impact. Investors are encouraged to consider other AI stocks with higher potential and less risk.

Jim Cramer discussed Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher, highlighting TMO’s potential but advising against immediate investment due to Chinese market uncertainties. TMO provides analytical instruments and lab products, but Cramer prefers Danaher for now. Investors are urged to wait for Chinese order pickup before considering TMO.

Although TMO shows promise, other AI stocks may offer better returns with lower risks. Investors seeking undervalued AI stocks can explore options beyond TMO. Cramer’s analysis of TMO and Danaher suggests caution due to market conditions, particularly related to China. Consider other AI stock opportunities for potential growth.

Read more at Yahoo Finance: “They Really Got Hurt By COVID”